2 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Study to Evaluate the Safety and Efficacy of BF-200 ALA (Ameluz®) and BF-RhodoLED® in the Treatment of Superficial Basal Cell Carcinoma (sBCC) With Photodynamic Therapy (PDT).Superficial Basal Cell CarcinomaActive, not recruitingPhase 32026-01-14NCT03573401
Neo-adjuvant Treatment for Squamous Cell Carcinoma Using Direct Tumor Injection With RP1.Neoplasms by Histologic Type, carcinoma, epithelial neoplasm, neoplasm, retinitis pigmentosa 1, squamous cell carcinoma, squamous cell neoplasmActive, not recruitingPhase 1 / Phase 22025-12-31NCT05858229